The A-share innovative drug sector fell in early trading, with Changshan Pharmaceutical down nearly 9%, Yuandong Bio and Baiyang Pharmaceutical down more than 4%, and Yifang Bio, Bibete and BeiGene down more than 3%.

2025-11-04

The A-share innovative drug sector fell in early trading, with Changshan Pharmaceutical down nearly 9%, Yuandong Bio and Baiyang Pharmaceutical down more than 4%, and Yifang Bio, Bibete and BeiGene down more than 3%.